ArticleLupus science & medicine2015

Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study.

Murray B Urowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.